Registro Colombiano de Enfermedades Glomerulares (Reglocol): informe preliminar

datacite.rightshttp://purl.org/coar/access_right/c_abf2
dc.contributor.authorAroca-Martinez, Gustavo
dc.contributor.authorFigueroa Millán , Christian Camilo
dc.contributor.authorDaza, Jose Lucas
dc.contributor.authorCadena Bonfanti, Andres Angélo
dc.contributor.authorPérez Jiménez, Valentina
dc.contributor.authorLASSO LATORRE, KAREN GISELLE
dc.contributor.authorTorres Saltarín, Jaime José
dc.contributor.authorCotes Araujo, Luis Andrés
dc.contributor.authorPuche Carrascal, Eduardo
dc.contributor.authorHernandez Agudelo, Sandra
dc.contributor.authorPérez Padilla, Rafael
dc.contributor.authorPeña Vargas , William arturo
dc.contributor.authorCastillo Parodi, Luis
dc.contributor.authorRiascos, William
dc.contributor.authorCastro Ahumada, Eddie
dc.contributor.authorRamirez-Marmolejo, Roberto
dc.contributor.authorAHUMADA NOLASCO, GUSTAVO
dc.contributor.authorRodriguez, Liliana
dc.contributor.authorSoto-Morón, Andrés
dc.contributor.authorVizcaino figueroa, Zoyla
dc.contributor.authorNatib, Danna
dc.contributor.authorAroca Vidal, María
dc.contributor.authorFontalvo Avila, Nicoll
dc.contributor.authorCAMARGO RODRIGUEZ, KANERY MARCELA
dc.contributor.authorVasquez Obeso, Esteban De Jesus
dc.date.accessioned2025-10-30T21:21:31Z
dc.date.available2025-10-30T21:21:31Z
dc.date.issued2025
dc.description.abstractContexto: las enfermedades glomerulares son una causa relevante de morbilidad renal y se clasifican en primarias y secundarias. En América Latina predominan las formas secundarias asociadas a lupus. En Colombia, el Registro REGLOCOL busca caracterizar su perfil clínico, histológico y terapéutico para fortalecer la investigación en nefrología. Objetivo: describir las características demográficas, clínicas e histopatológicas de los pacientes incluidos en la fase preliminar del Registro Colombiano de Enfermedades Glomerulares (Reglocol). Métodos: se realizó un estudio descriptivo de corte transversal que analizó 900 reportes de biopsia renal procedentes de 11 centros de nefrología en Colombia, recolectados entre 2010 y 2025. Se obtuvieron variables demográficas, clínicas e histopatológicas a partir de formularios estandarizados. Se aplicó estadística descriptiva y los resultados se expresaron en frecuencias, medias y medianas con rangos intercuartílicos. Resultados: de las 900 biopsias revisadas, 864 cumplieron criterios de inclusión. Las glomerulopatías primarias representaron el 70,7 % de los casos, mientras que las secundarias constituyeron el 29,3 %. Los diagnósticos más frecuentes fueron nefritis lúpica (22,8 %), glomeruloesclerosis focal y segmentaria (22,1 %), glomerulonefritis membranoproliferativa (14,1 % y nefropatía por inmunoglobulina A (IgA) (12,0 %). Se observó predominio del sexo femenino (56,8 %), etnia mestiza (88,5 %) y edades entre 30 y 59 años (42,4 %). El síndrome nefrótico (39,8 %) y la hipertensión arterial (35,3 %) fueron las presentaciones clínicas más comunes. La mayor concentración de casos se registró en la región Caribe, correspondiente a los centros participantes. Conclusiones: los hallazgos preliminares del Reglocol evidenciaron que las glomerulopatías en Colombia afectan predominantemente a mujeres en edad productiva, siendo la nefritis lúpica y la glomeruloesclerosis focal y segmentaria las entidades más prevalentes. Reglocol representa un avance significativo en la caracterización nacional de las enfermedades glomerulares y constituye la base para futuros estudios multicéntricos sobre determinantes epidemiológicos, genéticos y ambientales de la enfermedad renal en América Latina.spa
dc.description.abstractBackground: Glomerular diseases are a significant cause of renal morbidity and are classified as primary or secondary. In Latin America, secondary forms associated with lupus are predominant. In Colombia, the REGLOCOL Registry aims to characterize their clinical, histological, and therapeutic profiles to strengthen nephrology research. Objective: To describe the demographic, clinical, and histopathological characteristics of patients included in the preliminary phase of the Colombian Registry of Glomerular Diseases (REGLOCOL). Methods: A descriptive cross-sectional analysis of 900 biopsy reports from 11 nephrology centers across Colombia was conducted between 2010 and 2025. Clinical, demographic, and histopathological data were extracted from standardized forms. Descriptive statistics were used to summarize the data, which are presented as frequencies, means, and medians with interquartile ranges. Results: Of the 900 biopsies reviewed, 864 met inclusion criteria. Primary glomerulopathies accounted for 70.7 % of cases, while secondary forms represented 29.3 %. The most frequent diagnoses were lupus nephritis (22.8 %), focal and segmental glomerulosclerosis (22.1 %), membranoproliferative glomerulonephritis (14.1 %), and IgA nephropathy (12 %). The cohort was predominantly female (56.8 %), of mestizo ethnicity (88.5 %), and aged 30-59 years (42.4 %). The most common clinical presentation was nephrotic syndrome (39.8 %), followed by arterial hypertension (35.3 %). Regional distribution revealed a higher concentration of cases in the Caribbean region, which corresponded to the larger number of participating centers located in that region. Conclusions: Preliminary findings from REGLOCOL reveal that glomerular diseases in Colombia predominantly affect women of productive age, with lupus nephritis and focal and segmental glomerulosclerosis as the leading entities. REGLOCOL represents a milestone in the national characterization of glomerular pathology and establishes a foundation for future multicenter studies aimed at understanding epidemiological, genetic, and environmental determinants of kidney disease in Latin America.eng
dc.format.mimetypepdf
dc.identifier.citationAroca Martínez G, Figueroa Millan C, Daza JL, Cadena Bonfanti A, Pérez Jiménez V, Lasso Latorre K, et al. Registro Colombiano de Enfermedades Glomerulares (Reglocol): informe preliminar. Rev. Colomb. Nefrol. 2025; 12(3), e1065. https://doi.org/10.22265/acnef.12.3.1065
dc.identifier.doihttps://doi.org/10.22265/acnef.12.3.1065
dc.identifier.issn25005006
dc.identifier.issn23897708 (en línea)
dc.identifier.urihttps://hdl.handle.net/20.500.12442/17074
dc.identifier.urlhttps://revistanefrologia.org/index.php/rcn/article/view/1065
dc.language.isospa
dc.publisherAsociación Colombiana de Nefrología e Hipertensión Arterialspa
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationaleng
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceRevista Colombiana de Nefrologíaspa
dc.sourceVol. 12, Núm. 3, (2025)spa
dc.subjectGlomerulopatíasspa
dc.subjectNefritis lúpicaspa
dc.subjectGlomeruloesclerosis focal y segmentariaspa
dc.subjectBiopsia renalspa
dc.subjectEpidemiologíaspa
dc.subject.keywordsGlomerulopathieseng
dc.subject.keywordsLupus nephritiseng
dc.subject.keywordsFocal segmental glomerulosclerosiseng
dc.subject.keywordsKidney biopsyeng
dc.subject.keywordsEpidemiologyeng
dc.titleRegistro Colombiano de Enfermedades Glomerulares (Reglocol): informe preliminarspa
dc.title.translatedColombian Registry of Glomerular Diseases (Reglocol): preliminary reporteng
dc.type.driverinfo:eu-repo/semantics/article
dc.type.spaArtículo científico
dcterms.referencesWang X, Liu Z, Yi N, Li L, Ma L, Yuan L, et al. The global burden of chronic kidney disease due to glomerulonephritis: trends and predictions. Int Urol Nephrol. 2025;57(8):2613-24. https://doi.org/10.1007/s11255-025-04440-2spa
dcterms.referencesRodelo-Ceballos J, Chávez-Gómez WF, Taborda-Murillo A, Arias LF. Epidemiology of glomerular diseases in a Colombian population. Rev Esp Patol. 2025;58(3):100813. https:// doi.org/10.1016/j.patol.2025.100813spa
dcterms.referencesLópez-Gómez JM, Rivera F. Registro de glomerulonefritis de la Sociedad Española de Nefrología en 2019: pasado, presente y nuevos retos. Nefrología. 2020;40(4): 371-383. https:// doi.org/10.1016/j.nefro.2020.04.012spa
dcterms.referencesGhaddar M, Canney M, Barbour SJ. IgA nephropathy: epidemiology and disease risk across the world. Semin Nephrol. 2024;44(5):151564. https://doi.org/10.1016/j.semnephrol. 2025.151564spa
dcterms.referencesdo Nascimento Costa DM, Valente LM, da Cruz Gouveia PA, Sarinho FW, Fernandes GV, Gomes de Mattos Cavalcante MA, et al. Comparative analysis of primary and secondary glomerulopathies in the northeast of Brazil: data from the Pernambuco Registry of Glomerulopathies. J Bras Nefrol. 2017;39(1):29-35. https://doi.org/10.5935/0101-2800.20170005spa
dcterms.referencesValdez-Yánez G, Hernández-Pacheco J, Arellán-Bravo L, Velásquez-Castillo P, Matias- Tasayco V, Espinoza-Verástegui J, et al. Glomerulonefritis por biopsia en población atendida en el Hospital Nacional Dos de Mayo. Lima, 2007-2016. An Fac Med. 2018;79(2):115-8. http://dx.doi.org/10.15381/anales.v79i2.14936spa
dcterms.referencesGarau M, Cabrera J, Ottati G, Caorsi H, González Martínez F, Acosta N, et al. Temporal trends in biopsy-proven glomerular disease in Uruguay, 1990-2014. PLoS One. 2018;13(10):e0206637. https://doi.org/10.1371/journal.pone.0206637spa
dcterms.referencesKidney Disease: Improving Global Outcomes (KDIGO) ANCAVasculitisWork Group. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis. Kidney Int. 2024;105(3):S71-116. https://doi.org/ 10.1016/j.kint.2023.10.008spa
dcterms.referencesNoronha IL, Ramalho RJ, Costa de Oliveira CM, Bahiense-Oliveira M, Marques Barbosa FA, Barros Neto JR, et al. Implementation and first report of the Brazilian Kidney Biopsy Registry. PLoS One. 2025;20(2):e0312410. https://doi.org/10.1371/journal.pone.0312410spa
dcterms.referencesDurán CE, Ramírez A, Posada JG, Schweineberg J, Mesa L, Pachajoa H, et al. Prevalence of APOL1 risk variants in Afro-descendant patients with chronic kidney disease in a Latin American country. Int J Nephrol. 2019;2019:7076326. https://doi.org/10.1155/2019/7076326spa
dcterms.referencesNadkarni GN, Gignoux CR, Sorokin EP, Daya M, Rahman R, Barnes KC, et al.Worldwide frequencies of APOL1 renal risk variants. N Engl J Med. 2018;379(26):2571-2. https://doi.org/ 10.1056/nejmc1800748spa
dcterms.referencesRodelo J, Aguirre L, Ortegón K, Ustáriz J, Calderón L, Taborda A, et al. Predicting kidney outcomes among Latin American patients with lupus nephritis: the prognostic value of interstitial fibrosis and tubular atrophy and tubulointerstitial inflammation. Lupus. 2023;32(3):411-23. https://doi.org/10.1177/09612033231151597spa
dcterms.referencesGhaddar Glassock RJ. An Expert Opinion on Current and Future Treatment Approaches in IgA Nephropathy. Advances in Therapy. 2025;42:2545-2558. https://doi.org/10.1007/ s12325-025-03187-7spa
dcterms.referencesUbara Y, Sawa N, Yamanouchi M, Kono K, Ohashi K. New interpretation of diabetic nephropathy or diabetic kidney disease from kidney biopsy: review article. Clin Exp Nephrol. 2025;29(7):875-87. https://doi.org/10.1007/s10157-025-02661-4spa
dcterms.referencesBermejo S, González E, López-Revuelta K, Ibernon M, López D, Martín-Gómez A, et al. A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study. Nefrologia. 2025;45(5):360- 8. https:// doi.org/10.1016/j.nefroe.2025.04.004spa
dcterms.referencesJiang M, Chen H, Luo J, Chen J, Gao L, Zhu Q. Characterization of diabetic kidney disease in 235 patients: clinical and pathological insights with or without concurrent non-diabetic kidney disease. BMC Nephrol. 2025;26(1):29. https://doi.org/10.1186/ s12882-024-03931-1 ↑Ver página 14spa
oaire.versioninfo:eu-repo/semantics/publishedVersion

Archivos

Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
PDF.pdf
Tamaño:
1.7 MB
Formato:
Adobe Portable Document Format
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
381 B
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones